CCTST Research Ethics, Methods Grants Available
Applications are due by midnight Friday, Jan. 25, 2013 for innovative research addressing ethical issues in clinical and translational research, and biostatistical, epidemiological, and other methods developments.
The Research Ethics Grant Program supports interdisciplinary empirical research and faculty summer research fellowships that aim to develop, inform, or apply morally, socially and culturally acceptable frameworks that maximize the ethics of conducting clinical and translational research.
Collaborations of clinical investigators, ethicists, and behavioral/social scientists on interdisciplinary empirical research are strongly encouraged.
The Methodologic Research Program advances methodologic research in biostatistics, epidemiology, bioinformatics and related disciplines in order to enhance the capacity to conduct and analyze data from clinical and translational studies.
Promising innovations with potentially important applications that may enhance validity, efficiency, and causal inference of clinical and translational studies are supported. Relevance for clinical and translational research is a key evaluation criterion, and coordination with ongoing CCTST research is encouraged.
Each program expects to make 2 to 3 non-renewable 1-year awards of up to $10,000 (up to $8,000 for the ethics faculty summer fellowship). All 80% or greater FTE faculty members based at UC, Cincinnati Childrens or the Cincinnati VA Medical Center are eligible to apply.
Applicants must be CCTST members; join free of charge at cctst.uc.edu/user/register.
Complete program details are available at cctst.uc.edu/funding/methods_ethics, or email catherine.scharf@cchmc.org.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.